Purillex® Fluoropolymer Containers for Tissue Handling and Transport

Significance of the Topic

Tissue transport and handling are critical in tissue engineering and regenerative medicine to preserve cell viability and ensure patient safety. Standard lab containers often introduce extractables and leachables, threatening tissue health and regulatory compliance. The Purillex® PFA fluoropolymer containers address these challenges by offering an inert, low-contaminant storage solution that supports workflows from research to clinical application.

Objectives and Overview of the Article

This data sheet aims to present the design, validation, and performance of Purillex containers for tissue handling and transport. It highlights their material composition, seal integrity, validation package, and suitability for both R&D and commercial bioprocessing applications.

Methodology

The development approach included:

• Selection of high-purity virgin perfluoroalkoxy (PFA) fluoropolymer to minimize extractables and leachables.
• Design of a ferrule-style closure system validated to withstand cold chain conditions down to liquid nitrogen temperatures.
• Comprehensive testing: pressure decay, ASTM leakproof, shipping simulation, vacuum resistance, and burst pressure assays.
• Completion of USP Class VI biocompatibility testing and manufacturing lot traceability.

Instrumentation

The Purillex product line comprises jars, bottles (33 mm and GL45 closures), and vials manufactured from the same virgin PFA resin. Closures are screw-threaded ferrule-style caps requiring no additional gaskets or inserts. Options include pre-sterilization to SAL 10⁻⁶ and accessory fittings such as drains and porting inserts.

Main Results and Discussion

Performance evaluation demonstrated:

• Extremely low extractables and leachables, preserving tissue and cell culture viability compared to standard polymer vessels.
• Consistent, leak-free sealing across a broad temperature range, confirmed by container closure integrity testing (CCIT).
• Robust performance under simulated shipping stresses and pressure differentials.
• Regulatory readiness with an FDA-approved application in autologous tissue transplantation.

Benefits and Practical Applications of the Method

Purillex containers offer:

• Enhanced tissue and cell health due to inert surface chemistry.
• Streamlined workflows from R&D to commercialization by using a single validated container.
• Regulatory confidence via USP Class VI certification and complete validation documentation.
• Flexibility of container formats and pre-sterilization options to suit diverse tissue handling protocols.

Future Trends and Applications

Emerging demands in regenerative medicine and cell therapy suggest an increased need for single-use, high-integrity containers compatible with automated handling systems and closed bioprocessing platforms. Further material innovations may yield even lower extractable profiles, while integrated sensors could enable real-time monitoring of storage conditions.

Conclusion

Purillex PFA fluoropolymer containers deliver a validated, inert solution for critical tissue handling and transport challenges. Their combination of ultralow extractables, robust sealing, and regulatory support positions them as a best-in-class option for both research and clinical bioprocessing workflows.